racemetirosine has been researched along with Adipocere in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charron, G | 1 |
| Doudnikoff, E | 1 |
| Laux, A | 1 |
| Berthet, A | 1 |
| Porras, G | 1 |
| Canron, MH | 1 |
| Barroso-Chinea, P | 1 |
| Li, Q | 1 |
| Qin, C | 1 |
| Nosten-Bertrand, M | 1 |
| Giros, B | 1 |
| Delalande, F | 1 |
| Van Dorsselaer, A | 1 |
| Vital, A | 1 |
| Goumon, Y | 1 |
| Bezard, E | 1 |
1 other study available for racemetirosine and Adipocere
| Article | Year |
|---|---|
Endogenous morphine-like compound immunoreactivity increases in parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; alpha-Methyltyrosine; Analysis of Variance; Anim | 2011 |